Verily

News

Koneksa aims to answer Parkinson's-tracking challenge with A...

Healthcare technology firm Koneksa will carry out a study to evaluate whether digital biomarkers can be used to track the progression of Parkinson's disease – thanks to a grant from the Mic

News

Verily taps Oncimmune tech for 'long COVID' study

Alphabet's Verily Life Science has contracted UK biotech Oncimmune to investigate autoantibodies in people who have developed long-lasting symptoms after COVID-19 infection, a condition kno

News

GSK, Verily-backed Galvani starts trials of bioelectronic ar...

The first patient has been treated with an implantable bioelectronic device developed by Galvani Therapeutics, set up by GlaxoSmithKline and Alphabet's Verily Life Sciences in 2016.

News

Novi Sad, Serbia - October 6, 2014: Woman's hands Googling on electronic device.Woman hands holding and touching on Apple iPad mini with Google search web page on a screen.

Otsuka, Click trial digital depression therapy with Google

Otsuka and Click Therapeutics are working with Verily, the healthcare subsidiary of Google owners Alphabet, on a fully remote clinical trial testing a digital therapy as an add-on in adults

News

Google’s Verily eyes 2021 growth after $700m funding round

Verily is planning “significant and focused growth” in 2021 after closing a $700 million funding round from investors including its parent company, and Google holding firm, Alphabet.

News